Published in PLoS One on August 14, 2017
Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol (2001) 7.27
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med (2004) 3.83
Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol (2006) 2.80
IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol (2003) 2.62
Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol (2004) 2.15
Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev (2010) 2.10
Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol (2003) 1.94
Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clin Exp Allergy (2010) 1.72
Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration. Pediatr Allergy Immunol (2008) 1.64
Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy (2001) 1.56
Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy (2006) 1.40
Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol (2008) 1.38
Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol (1997) 1.27
Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clin Exp Allergy (2011) 1.09
Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy (2000) 1.08
Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pediatr Allergy Immunol (2007) 1.01
Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol (2001) 1.00
Dose response of IgE and IgG antibodies during ragweed immunotherapy. J Allergy Clin Immunol (1984) 0.98
Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol (2006) 0.97
Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol (2007) 0.97
Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol (2003) 0.95
Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol (1997) 0.94
Variability of offending allergens of allergic rhinitis according to age: optimization of skin prick test allergens. Allergy Asthma Immunol Res (2013) 0.93
Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan. Respir Med (2006) 0.91
House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy (2000) 0.91
Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children. Ann Allergy Asthma Immunol (1999) 0.90
Sensitization to airborne allergens in children with respiratory symptoms. Ann Allergy Asthma Immunol (1996) 0.86
The longest wheal diameter is the optimal measurement for the evaluation of skin prick tests. Int Arch Allergy Immunol (2009) 0.84
Three-Year Follow-up Results of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitized to House Dust Mites. Allergy Asthma Immunol Res (2014) 0.82
Clinical efficacy and tolerance of two year Lolium perenne sublingual immunotherapy. Allergol Immunopathol (Madr) (1997) 0.80
Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Respir Med (2013) 0.79
Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. J Allergy Clin Immunol (2016) 0.78
Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial. J Investig Allergol Clin Immunol (2015) 0.78
Efficacy of long-term sublingual-oral immunotherapy in allergic rhinitis. Acta Otorhinolaryngol Ital (2005) 0.75
Clinical characteristics of allergic rhinitis according to allergic rhinitis and its impact on asthma guidelines. Clin Exp Otorhinolaryngol (2008) 0.81
Acute High-Dose and Chronic Lifetime Exposure to Alcohol Consumption and Differentiated Thyroid Cancer: T-CALOS Korea. PLoS One (2016) 0.80
KOHBRA BRCA risk calculator (KOHCal): a model for predicting BRCA1 and BRCA2 mutations in Korean breast cancer patients. J Hum Genet (2016) 0.78
Autologous vs Irradiated Homologous Costal Cartilage as Graft Material in Rhinoplasty. JAMA Facial Plast Surg (2017) 0.75
Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study. Clin Exp Nephrol (2016) 0.75
Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication success. Helicobacter (2019) 0.75